A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns-Reference-Cited by-同舟云学术

A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns

Published:2023-11-02 Issue:6 Volume:28 Page:308-312
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Guida Maurizio¹,Quercitelli Luciano¹,De Franciscis Pasquale²,Ferrara Cinzia¹,Marietta Marco³,Iaccheri Mattia³,Facchinetti Fabio³,Capasso Filomena⁴,Grandi Giovanni³

Affiliation:

1. Obstetrics and Gynecology, University Federico II, Naples, Italy

2. Department of Obstetrics and Gynecology, University of Campania “Luigi Vanvitelli”, Naples, Italy

3. Obstetrics and Gynecology, Obstetrics and Gynecology Unit, University of Modena and Reggio Emilia, Modena, Italy

4. Laboratory of Hemostasis and Thrombosis, AOU Federico II, Naples, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2023.2276668

Reference32 articles.

1. Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception

2. Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature

3. Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception

4. Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability

5. WHO. Medical eligibility criteria for contraceptive use. 5th ed. Geneve (Switzerland): World Health Organization; 2015.